D-Feet Cancer The Dalton Fox Found… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

William P Fox

Phone

7572329276

Tax Period

2024-01-01 to 2024-12-31

D-Feet Cancer The Dalton Fox Foundation, founded in 2021, is a small nonprofit in the Medical Research sector that reported $166K in total revenue in fiscal year 2024. Revenue decreased 16% compared to the prior year.

Mission

D-Feet Cancer The Dalton Fox Foundation raises awareness of Ewing Sarcoma and other under-studied pediatric cancers. By directly funding research into these cancers, we are determined to help discover more effective and less toxic treatments while supporting both patients and families during their greatest time of need.

Program Service Accomplishments

Program 1

Expenses: $180,805 Revenue: $165,673

Bring awareness and provide funding for Ewing Sarcoma cancer research

Program 2

N/A

Program 3

N/A

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $42,226

Program Service Revenue $118,461

Investment Income $4,986

Other Revenue $0

TOTAL REVENUE $165,673

Expense Breakdown

Grants Paid $150,000

Salaries & Benefits $0

Fundraising Expenses $1,257

Program Expenses $180,805

Other Expenses $30,805

TOTAL EXPENSES $180,805

Year-over-Year Comparison

	2024	2023	Change
Revenue	$165,673	$197,325	-0.2%
Expenses	$180,805	$128,340	+0.4%
Net Income	$-15,132	$68,985	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Victor Bakkar	President	0	Officer Director	$0	$0	$0
Jennifer Fox	Vice President	N/A	Officer Director	$0	$0	$0
William Fox	Treasurer	0	Officer Director	$0	$0	$0
Melissa Disher	Secretary	0	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$165,673	$180,805	$196,827	$-15,132
2023	$197,325	$142,843	$211,705	$54,482
2022	$158,600	$28,340	$156,477	$130,260
2021	$57,219	$31,002	$26,217	$26,217

D-Feet Cancer The Dalton Fox Foundation